Insurance Type and Menopausal Hormone Therapy Use Among US Women - Takeaways - MDSpire

Insurance Type and Menopausal Hormone Therapy Use Among US Women

  • By

  • Arina Chesnokova

  • Sunni L. Mumford

  • Allison Schachter

  • Rebecca F. Hamm

  • Scott Lorch

  • Matthew Klebanoff

  • Sarah Lindley

  • Erika Harness

  • Makeba Williams

  • Marilyn M. Schapira

  • July 17, 2026

Share

  • 1

    Menopause typically occurs between ages 45 and 55 and is often accompanied by bothersome symptoms like vasomotor symptoms (VMS).

  • 2

    Menopausal hormone therapy (MHT) is the first-line treatment for bothersome VMS but has seen low initiation rates since the Women’s Health Initiative trial results.

  • 3

    Black or African American individuals report more severe VMS but receive less MHT treatment compared to White individuals.

  • 4

    Insurance coverage significantly influences access to MHT, with Medicaid covering a disproportionate number of minoritized individuals.

  • 5

    The study investigates the association between insurance type and MHT use among women aged 45 to 64, focusing on disparities in treatment rates.

Original Source(s)

Insurance Type and Menopausal Hormone Therapy Use Among US Women

  • by Arina Chesnokova, Sunni L. Mumford, Allison Schachter, Rebecca F. Hamm, Scott Lorch, Matthew Klebanoff, Sarah Lindley, Erika Harness, Makeba Williams, Marilyn M. Schapira

  • July 17, 2026

Related Content

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

Hot flashes: a review

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.